- Category: Experimental HCV Drugs
- Published on Friday, 26 September 2014 00:00
- Written by HIVandHepatitis.com
A Phase 2 clinical trial is now underway to evaluate sofosbuvir (Sovaldi) plus ribavirin for children and adolescents, ages 3-17 years, with hepatitis C virus genotypes 2 or 3. Another study will follow to test the forthcoming sofosbuvir/ledipasir coformulation in pediatric patients.